Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Cann Group Limited (CAN)
Sign up for free Sign up for free Sign up for free

Cann Group Limited (ASX: CAN) - Share Price and Research

- Current share price for CAN : $0.027

Cann Group Limited (CAN), an ASX-listed company, is enhancing patients lives by developing, producing, and supplying innovative cannabis medicines. The Company has research facilities and corporate headquarters in Melbourne and operates a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world.

CAN General Information +

ASX Code CAN
Website http://www.canngrouplimited.com
Industry/Sector Pharmaceuticals
Market Cap ($M) 15
CAN Share Price $0.027
Day High $0.000
Day Low $0.000
Last Close $0.027
CAN Share Price Movement - ( No change )
Prices as at 16:40, 4 Apr 2025
+Security prices are delayed by at least 20 minutes and are indicative only.
Trial Banner Trial Banner Trial Banner
Upsell Banner

CAN Related Research

Cann Group Limited (CAN) Upcoming Dividends & Yields

There are no dividends for Cann Group Limited (CAN). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cann Group Limited (CAN) price-sensitive announcements

CAN - Trading Halt
Cann Group Limited has requested a trading halt for its shares pending an announcement reg
Cann Group Limited (CAN)
4 Apr 2025 | 10:15 AM
CAN - Pause in Trading
Cann Group Limited has announced a temporary pause in trading of its securities. This paus
Cann Group Limited (CAN)
4 Apr 2025 | 9:56 AM
CAN - Chemist Warehouse Announcements - Supplementary Information
Cann Group Limited announced the execution of supply agreements with eleven Chemist Wareho
Cann Group Limited (CAN)
3 Apr 2025 | 1:41 PM
CAN - Selected Chemist Warehouse (QLD) Supply Agreements Executed
Cann Group Limited has announced the execution of supply agreements with eleven Chemist Wa
Cann Group Limited (CAN)
3 Apr 2025 | 9:27 AM

See more price-sensitive ASX announcements or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

Cann Group Limited (CAN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Trading Halt 4 Apr 2025 10:15AM $0.027 $0.027 fallen by 0%
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Pause in Trading 4 Apr 2025 9:56AM $0.027 $0.027 fallen by 0%
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Chemist Warehouse Announcements - Supplementary Information 3 Apr 2025 1:41PM $0.027 $0.027 fallen by 0%
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Selected Chemist Warehouse (QLD) Supply Agreements Executed 3 Apr 2025 9:27AM $0.023 $0.027 risen by 17.39%
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Application for quotation of securities - CAN 3 Apr 2025 9:21AM $0.023 $0.027 risen by 17.39%
Cann Group Limited (CAN)
ORDINARY FULLY PAID
 Health Care $15 Application for quotation of securities - CAN 3 Apr 2025 9:21AM $0.023 $0.027 risen by 17.39%

CAN Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2024A -$30.68 -$6.80 -19.70% 0.00 0.00 0.00% 0.0%
2023A -$33.12 -$8.40 13.60% 0.00 0.00 0.00% 0.0%
2022A -$26.44 -$7.40 -19.00% 0.00 0.00 0.00% 0.0%

CAN Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2022 A 2023 A 2024 A 2022 A 2023 A 2024 A 2022 A 2023 A 2024 A
Botanix Pharmaceuticals (BOT) $779M 0.1646 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cann Group (CAN) $15M -0.1971 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Clarity Pharmaceuticals (CU6) $609M 0.6392 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mayne Pharma Group (MYX) $587M -0.4117 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals (NEU) $1,332M -0.0957 -0.1898 0.0000 9.7321 12.0114 0.0000 0.00% 0.00% 0.00%

CAN Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.92 0.00
Market 0.20 13.10 1.03 0.73
Sector 0.83 18.60 1.95 1.71

CAN Directors

Name Position Start Date
Ms Jennifer (Jenni) Pilcher Chief Executive Officer, Managing Director 8 Sep 2020
Mr Allan D McCallum Non-Executive Chairman, Non-Executive Director 30 Jan 2015
Mr Douglas (Doug) John Rathbone Non-Executive Director 16 Mar 2015
Mr Peter Kopanidis Non-Executive Director 31 Mar 2025

Cann Group Limited (CAN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
2 Dec 2024 CHICK, Julian Issued Indirect Shares 83,334 $0.040 $3,333.360
2 Dec 2024 BARNES, Robert Issued Indirect Shares 66,667 $0.040 $2,666.680
2 Dec 2024 RATHBONE, Douglas (Doug) Issued Indirect Shares 60,000 $0.040 $2,400.000

See all changes in directors' interest & trades for Cann Group Limited (CAN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

CAN Management

Name Position
Tony Di Pietro Chief Financial Officer
Steven Notaro Company Secretary

CAN Calendar of Events

Date Event
27 February 2026 Report (Interim)
12 September 2025 Report (Annual)
29 August 2025 Report (Prelim)
07 May 2025 Report (Interim)

FAQs about Cann Group Limited (CAN)

Cann Group Limited's (CAN) current share price is $0.03. This constitutes a price movement of 8% when compared to the share price 7 days ago and is -71.58% below CAN's 12-month high of $0.10 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.03, Cann Group Limited's (CAN) current share price of $0.03 constitutes a movement of or 0%. Cann Group Limited's (CAN) share price movement is 8% when compared to 7 days ago and is -71.58% below CAN's 52-week high of $0.10.

Cann Group Limited's (CAN) 52-week high is $0.10 which was reached on 30 Sep 2024. Relative to this, CAN's current share price of $0.03 constitutes a -$0.07 or -71.58% drop since that high of $0.10 per CAN share.

Cann Group Limited's (CAN) 52-week low is $0.02 which was reached on 24 Mar 2025. Relative to this, CAN's current share price of $0.03 constitutes a $0.00 or 17.39% gain since that low of $0.02 per CAN share.

Over the last 12 months, Cann Group Limited (CAN) has a daily average trading volume of 846,177 CAN shares per day.

Cann Group Limited (CAN) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for CAN is a ratio that tells you the percentage of Cann Group Limited's (CAN) share price that it pays out in dividends each year.

Cann Group Limited (CAN) will release its next Annual Report on 12 September 2025. Cann Group Limited's (CAN) last annual report was released on 13 Sep 2024. Click here to view Cann Group Limited's (CAN) last annual report.

Cann Group Limited (CAN) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Sigma Healthcare Limited (SIG), ResMed Inc. (RMD), and Pro Medicus Limited (PME).

The price-to-earnings (P/E) ratio for Cann Group Limited (CAN) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Cann Group Limited's (CAN) share price to its earnings per CAN share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.